HCV Anaesthesia
Conditions
Interventions
propofol
sevoflurane
propofol HCV NEGATIVE
sevoflurane HCV negative
Sponsors
Science and Technology Development Funds(STDF)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA II III Major surgery
Exclusion criteria
Exclusion criteria: ASA I,IV CANCER PATIENTS BLOOD DISEASES
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effect of study drugs on micro RNA | — |
Secondary
| Measure | Time frame |
|---|---|
| effect of study drugs on liver functions | — |
Countries
Egypt
Contacts
Public Contactola;ola zanaty;zanaty
;
Outcome results
None listed